Axel Grothey, MD - Exploring the Potential of Targeted Adjuvant Treatment and Individualized Therapy in Colorectal Cancer: Lessons from Orlando

Summary: In this activity, an expert in colorectal cancer (CRC) discusses the clinical implications of new and breaking data on the role of targeted agents as adjuvant therapy in early-stage CRC and the potential development of prognostic and predictive factors.